BioStock: Full speed ahead for BiBBInstruments after FDA clearance

2022 was intensive in terms of regulatory work for BiBBInstruments. The work started paying off in March this year when the medical technology company was awarded FDA clearance for the company's most important product, EndoDrill GI. The FDA clearance opened the door to the world's largest market for ultrasound-guided endoscopy. This also means that BiBB is a step closer to reaching a global distribution agreement. Looking ahead, clinical market activities in the US and a clinical multicentre study in pancreatic cancer in Sweden are expected.

Read the article at biostock.se:

https://www.biostock.se/en/2023/05/full-speed-ahead-for-bibbinstruments-after-fda-clearance/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/